Finance

Lists
PTX:ASX
Prescient Therapeutics Ltd
0,065 AUD
0,00%
(0,00) 1D
7-окт., 16:00:00 GMT+11  ·   AUD
All symbols
SymbolPriceChange% Change
Generating top insights for PTX...
Open
0,06 AUD
High
0,06 AUD
Low
0,06 AUD
Mkt. cap
79,31 млн
Avg. vol.
1,07 млн
Volume
536,71 миң
52-wk high
0,12 AUD
52-wk low
0,04 AUD
EPS
-0,01 AUD
Shares outstanding
1,14 млд
No. of employees
3
Open
0,06 AUD
High
0,06 AUD
Low
0,06 AUD
Mkt. cap
79,31 млн
Avg. vol.
1,07 млн
Volume
536,71 миң
52-wk high
0,12 AUD
52-wk low
0,04 AUD
EPS
-0,01 AUD
Shares outstanding
1,14 млд
No. of employees
3
News stories
From web sources and news partners
Profile
Prescient Therapeutics is a clinical-stage oncology company developing targeted therapies. Prescient's technologies emanate from prestigious world class centres including Yale, Penn, Oxford and Moffitt. Wikipedia
About Prescient Therapeutics Ltd
CEOSteven Yatomi-Clarke
Employees3
Founded1986-ж., 22-май
Headquarters-
Sector-
Previous reportsAll values in AUD
Loading Previous Earnings...
Revenue
Net income
All values in AUD
2025-ж. сен.
2025-ж. дек.
2026-ж. мар.
2026-ж. июн.
Revenue
578,89 миң
578,89 миң
1,15 млн
1,15 млн
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
1,24 млн
1,24 млн
1,40 млн
1,40 млн
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1,13 млн
1,13 млн
1,20 млн
1,20 млн
Operating expense
2,57 млн
2,57 млн
2,73 млн
2,73 млн
Total operating expenses
2,57 млн
2,57 млн
2,73 млн
2,73 млн
Operating income
-1,99 млн
-1,99 млн
-1,58 млн
-1,58 млн
Other non operating income
-
-
-
-
EBT including unusual items
-1,99 млн
-1,99 млн
-1,51 млн
-1,51 млн
EBT excluding unusual items
-1,99 млн
-1,99 млн
-1,51 млн
-1,51 млн
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-1,99 млн
-1,99 млн
-1,51 млн
-1,51 млн
Net profit margin
-344,35%
-344,35%
-131,51%
-131,51%
Earnings per share
-
-
-
-
Interest and investment income
1,86 миң
1,86 миң
67,39 миң
67,39 миң
Interest expense
-2,97 миң
-2,97 миң
-2,38 миң
-2,38 миң
Net interest expenses
-1,12 миң
-1,12 миң
65,02 миң
65,02 миң
Depreciation and amortization charges
-
-
-
-
EBITDA
-
-
-
-1,55 млн
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google колдонмолору